SB 14 Kentucky Senate · 2025 Regular Session

AN ACT relating to pharmaceutical manufacturers.

Summary
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2025
Committee Review
Feb 2025
Senate Passage
Feb 2025
House Passage
Governor
Introduced Jan 7, 2025 Last action Feb 14, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Current/Final · 2 edits
MINOR
The document underwent a technical renumbering and version update from a bill reference (BR 996) to the current Senate Bill number (SB 14), indicating progression through the legislative process. No substantive policy changes, eligibility criteria, funding amounts, or legal requirements were altered in this diff.
TECHNICAL

Bill reference number updated from BR 996 to SB 14/GA, reflecting the bill's current status in the legislative pipeline.

Document header metadata changed to reflect the new bill number and updated timestamp (3:51 PM vs 3:50 PM).

Floor votes · Senate Feb 13, 2025

How they voted

375
Passed · 1 other
Total votes 43
Feb 13, 2025
D Democratic6
5 Yea 1
83% Yea
R Republican37
32 Yea 5 Nay
86% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
12
Key actions
2
Committee
4
Amendments
1
Feb 14, 2025
Committee
to Committee on Committees (H)
lower
Feb 13, 2025
Upper · Passed
passed 33-4
upper
Feb 7, 2025
Introduced
floor amendments (1-title) and (2) filed
upper
Feb 5, 2025
Upper · Passed
reported favorably, 1st reading, to Calendar
upper
Jan 9, 2025
Committee
to Health Services (S)
upper
Jan 7, 2025
Committee
to Committee on Committees (S)
upper
Jan 7, 2025
Introduced
introduced in Senate
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.